NMRA
Neumora Therapeutics, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$1.31
−2.96%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -2.62x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.00x
- Net debt / EBITDA
- 0.56x
Liquidity & coverage
- Current ratio
- 4.50x
- Quick ratio
- 4.50x
- Cash ratio
- 4.21x
- Interest coverage
- -32.71x
- EBITDA / interest
- -32.08x
- Working capital
- $97.1M
Cash & dividend
- FCF / debt
- -530.94x
- Cash flow / debt
- -530.94x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026